LENBULT

Glaxo Group Limited

Application Filed: 2019-02-13
Trademark Application Details
Trademark Logo LENBULT

Mark For: LENBULT® trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines. [all]

Status

2020-09-12 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88299413
Registration Number5834788
Mark Literal ElementsLENBULT
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2019-08-13
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMerilee J. Arevalo
Attorney Docket Number82767480
Law Office AssignedL40
Employee NameMARTIN, CHRISTINE C

Timeline

2019-02-13Application Filed
2019-04-25Location: PUBLICATION AND ISSUE SECTION
2019-04-25Status: Live/Pending
2019-04-25Transaction Date
2019-05-28Published
2019-05-28Published for Opposition
2019-08-13Location: PUBLICATION AND ISSUE SECTION
2019-08-13Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-08-13Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Glaxo Group Limited
Address980 Great West Road Brentford, Middlesex UNITED KINGDOM TW89GS
Legal Entity TypePrivate Company Limited By Shares (prc)
Legal Entity StateENGLAND

Documents

DrawingJPEG2019-02-13
TEAS Plus New ApplicationMULTI2019-02-13
XSearch Search SummaryXML2019-04-23
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2019-04-24
Notice of PublicationXML2019-05-08
Notification Of Notice of PublicationXML2019-05-08
OG Publication ConfirmationAPPLICATION/XML2019-05-28
Registration CertificatePDF2019-08-13

Attorney of Record

MERILEE J. AREVALO
GSK
5 MOORE DRIVE
LBP, 5.5A
RESEARCH TRIANGLE PARK, NC 27709-3398

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2019-08-13
PUBLISHED FOR OPPOSITION2019-05-28
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-05-28
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-05-08
ASSIGNED TO EXAMINER2019-04-2385324
APPROVED FOR PUB - PRINCIPAL REGISTER2019-04-23
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-03-06
NEW APPLICATION ENTERED IN TRAM2019-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed